18 Biggest Mid-Day Gainers For Monday
- Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares climbed 68.8 percent to $9.88 after the company reported positive top line results from its second stage trial of Resunab (JBT-101) for systemic sclerosis treatment.
- DryShips Inc. (NASDAQ: DRYS) shares surged 64 percent to $22.30. DryShips shares have tumbled 94.67 percent over the past 52 weeks, while the S&P 500 index has increased 5.42 percent in the same period.
- Eagle Bulk Shipping Inc (NASDAQ: EGLE) shares rose 27.3 percent to $7.74. Eagle Bulk Shipping shares have dropped 91.89 percent over the past 52 weeks, while the S&P 500 index has gained 5.42 percent in the same period.
- Harman International Industries Inc (NYSE: HAR) shares surged 25.4 percent to $109.90 after Samsung Electronics announced plans to buy the company in an $8 billion deal.
- Mentor Graphics Corp (NASDAQ: MENT) shares jumped 18.8 percent to $36.46 after Siemens announced plans to acquire the company for $37.25 per share in cash.
- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares surged 18.1 percent to $3.39. Ocean Bio-Chem reported Q3 earnings of $0.17 per share on revenue of $12.207 million.
- Mechel PAO (ADR) (NYSE: MTL) shares jumped 18 percent to $6.43 after dropping 3.20 percent on Friday. Mechel reported its participation in the 22nd International Industrial Exhibition Metal-Expo held on November 8-11, 2016.
- Amaya Inc. (NASDAQ: AYA) shares climbed 15.6 percent to $15.73. Amaya posted upbeat Q3 earnings and issued a strong FY16 earnings forecast. Amaya’s former CEO, David Baazov, offered to acquire the company in a deal valued at around C$3.48 billion, or $2.56 billion.
- Eleven Biotherapeutics Inc (NASDAQ: EBIO) gained 15.3 percent to $3.02. Eleven Biotherapeutics posted Q3 earnings of $0.91 per diluted share on revenue of $28.65 million.
- Digi International Inc. (NASDAQ: DGII) gained 12.9 percent to $13.15. Belden Inc. (NYSE: BDC) proposed to buy Digi International for $13.82 per share. However, Digi International’s board confirmed the rejection of proposal from Belden.
- Ocular Therapeutix Inc (NASDAQ: OCUL) shares surged 12.7 percent to $7.74 positive topline results from a Phase 3 clinical trial of Dextenza that met primary endpoints for inflammation and pain primary efficacy.
- PTC Therapeutics, Inc. (NASDAQ: PTCT) gained 8.9 percent to $12.30. Credit Suisse upgraded PTC Therapeutics from Neutral to Outperform and raised the price target from $15.00 to $25.00.
- Chico's FAS, Inc. (NYSE: CHS) shares jumped 7.5 percent to $14.73. Citigroup upgraded Chico's FAS from Neutral to Buy.
- Kohl's Corporation (NYSE: KSS) rose 7.1 percent to $57.01. Citigroup upgraded Kohl's from Neutral to Buy.
- Regions Financial Corp (NYSE: RF) gained 6.8 percent to $13.30. FBR Capital upgraded Regions Financial from Market Perform to Outperform.
- AK Steel Holding Corporation (NYSE: AKS) shares gained 6.7 percent to $8.00. Morgan Stanley upgraded AK Steel from Equal-Weight to Overweight and raised the price target from $5.00 to $11.00.
- Quest Diagnostics Inc (NYSE: DGX) rose 4.7 percent to $85.25. UBS upgraded Quest Diagnostics from Neutral to Buy.
- Credit Suisse Group AG (ADR) (NYSE: CS) gained 3.3 percent to $14.69. Bank of America upgraded Credit Suisse from Neutral to Buy.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Mid-Day MoversNews Intraday Update Markets Movers
